Patent ID: 8604083
Filing Date: 2013-12-10
Classification: A01N,A61K,A61P,C07B,C07C,C07D,Y10S

Abstract:
1. A method for treating a mammalian subject with a condition selected from the group consisting of insulin resistance syndrome and Type II Diabetes, comprising administering to the subject an amount of a biologically active agent effective to treat the condition, wherein the agent is a compound of the formula: wherein n is 0, 1 or 2; R R R A is phenyl, unsubstituted or substituted by 1 or 2 groups selected from halo, alkyl having 1 or 2 carbon atoms, perfluoromethyl, alkoxy having 1 or 2 carbon atoms, and perfluoromethoxy; or or a pharmaceutically acceptable salt of the compound.